Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)

Overview of attention for article published in Clinical Ophthalmology, July 2013

Altmetric Badge

About this Attention Score

Good Attention Score compared to outputs of the same age (73rd percentile)
High Attention Score compared to outputs of the same age and source (89th percentile)

So far, Altmetric has seen 3 X posts from 3 X users, with an upper bound of 3,701 followers.

Initial non-responders to ranibizumab in the treatment of age-related #maculardegeneration (AMD) http://t.co/PjzAdTblh9

Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD) http://t.co/H0lxrzABFs